U.S. Banks Stock News

Despite an already strong run, Teekay Tankers Ltd. ( NYSE:TNK ) shares have been powering on, with a gain of 25% in the...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Cable One, Inc. ( NYSE:CABO ) shareholders that were waiting for something to happen have been dealt a blow with a 25...

Some The New York Times Company ( NYSE:NYT ) shareholders may be a little concerned to see that the CEO, President...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

NextNRG (NXXT) just signed a Memorandum of Understanding with Gulfstream Development Corporation to design and implement an AI-powered energy solution at a large-scale warehousing site near Port St. Lucie, Florida. The move highlights NextNRG’s expertise in next-generation energy and mobility infrastructure. See our latest analysis for NextNRG. Investors are taking notice of NextNRG after the Gulfstream announcement, with the share price jumping 18.75% in a day and surging 57.1% over the past...

PubMatic reported its third-quarter 2025 results last week, showing revenue of US$67.96 million and a net loss of US$6.45 million, both wider than the prior year period, but exceeding adjusted earnings and revenue expectations from analysts. The company spotlighted more than 50% year-over-year Connected TV ad revenue growth and emphasized the impact of its AI-driven innovations, developed with NVIDIA, which have contributed to increased publisher revenues and marketplace...

TreeHouse Foods (THS) shares have climbed roughly 25% over the past month. This increase has drawn attention from investors who are curious about the factors behind the stock’s recent momentum and where it could head next. See our latest analysis for TreeHouse Foods. After a rough start to the year, TreeHouse Foods’ recent 1-month share price return of nearly 25% stands out, especially since its total return over the past 12 months is still down around 25%. The latest rally suggests momentum...

Krispy Kreme (DNUT) is shaking things up this month with an expanded menu, rolling out nine brand new doughnut flavors and growing its everyday line-up to sixteen options. This refresh comes at the same time as a marketing push that channels a classic 1990s tune, sparking fresh buzz around the brand. See our latest analysis for Krispy Kreme. The new menu launch and nostalgia-fueled marketing push come at a time when Krispy Kreme’s momentum is especially volatile. While the company’s 1-month...

LiveWire Group (LVWR) updated its guidance for 2025, now expecting a wider operating loss range of $72 million to $77 million, up from its previous estimate. This announcement was released together with the company’s third-quarter earnings results and provided key updates for investors. See our latest analysis for LiveWire Group. LiveWire Group’s announcement of a wider expected operating loss for 2025 appears to have weighed on sentiment even as quarterly losses improved from last year. The...

Ultragenyx Pharmaceutical reported third quarter financials showing revenue of US$159.93 million and a net loss of US$180.41 million, while also reaffirming its 2025 total revenue guidance of US$640 million to US$670 million, expecting growth of 14-20% versus 2024. An important insight is that alongside its financial update, Ultragenyx advanced its rare disease pipeline by dosing the first patient in the Aurora study, broadening clinical reach for Angelman syndrome therapies, which could...

Uniti Group recently reported third-quarter 2025 earnings, revealing very large year-over-year increases in revenue (US$722.6 million) and net income (US$1.61 billion), along with raised full-year guidance. This earnings report indicates a significant operational shift and confidence in Uniti Group’s future, reflecting material progress in business execution and profitability. We'll examine how Uniti's dramatic earnings growth and improved guidance influence the company's long-term...

enGene Holdings recently reported additional preliminary efficacy data from its pivotal Phase 2 LEGEND trial for detalimogene voraplasmid in patients with high-risk, BCG-unresponsive non-muscle invasive bladder cancer, along with a protocol amendment changing the primary clinical endpoint after discussions with the FDA. This update reveals that earlier patients in the study experienced a lower 12-month complete response rate compared to FDA-approved therapies, leading to significant...

Curious if Ralliant is still a hidden gem, or if recent moves have pushed it into overvalued territory? Let’s break down the big questions around whether it deserves a spot on your watchlist. Ralliant’s stock has caught attention by rising 7.6% over the past week and jumping an impressive 14.2% in the last month. This suggests growing investor interest or shifting risk perceptions. In the backdrop, major partnership announcements and industry expansion news have kept Ralliant in the...

Avient Corporation recently reported its third-quarter 2025 financial results, posting sales of US$806.5 million and net income of US$32.6 million, both slightly below the previous year, alongside margins that improved due to effective cost controls. The company expects fourth-quarter sales to show modest improvement over the third quarter, supported by growth in its Specialty Engineered Materials segment and new product innovations. We'll explore how Avient’s improved profit margins and...

Wondering if now is the right time to buy Alkami Technology? With so many opinions out there, getting straight to the heart of whether the stock is good value can make all the difference. After climbing 8.3% in the last week, Alkami Technology is still down 10.7% over the past month and has fallen 44% year-to-date, pointing to both volatility and shifting market sentiment. Recent headlines have focused on Alkami’s expansion into new financial technology services and...

Kaltura (KLTR) just shared its quarterly earnings and new guidance for the rest of the year. The update offers fresh insights into the company’s financial health and what investors might expect in the coming months. See our latest analysis for Kaltura. Kaltura’s share price showed a burst of short-term momentum lately, climbing 15.2% over the last month after a much slower start to the year. Despite the latest guidance and buyback update, the overall one-year total shareholder return is still...

DHT Holdings (DHT) just released its latest earnings, showing net income growth and better earnings per share for the third quarter and the first nine months compared to last year. This signals a clear uptick in profitability. See our latest analysis for DHT Holdings. Momentum is clearly building for DHT Holdings, with the share price climbing 17.1% over the last month and an impressive 38.6% year-to-date. Taking dividends into account, the total shareholder return over the past year stands...

Upstream Bio (UPB) just released its third-quarter earnings along with a new shelf registration filing, giving investors plenty to consider. Sales rose year over year, although the company’s net loss also widened during the quarter. See our latest analysis for Upstream Bio. After the earnings release and shelf registration announcement, Upstream Bio’s share price surged 21.2% over the past month and is up an impressive 45.9% year-to-date, showing a sharp improvement in sentiment even as its...

Wondering if Intellia Therapeutics is undervalued, overpriced, or finally at a sweet spot? You are definitely not alone, as many investors are asking the same question with all the action in biotech stocks lately. After a tough few weeks, Intellia’s share price has fallen by 16.6% in just the past 7 days and is down 58.5% over the last month. This may have some wondering if the market sees hidden risks or changing prospects. Much of this recent volatility has been attributed...

Surf Air Mobility (NYSE:SRFM) just announced a $100 million strategic transaction, which features new equity and debt refinancing. This move aims to accelerate development of SurfOS and push Q3 revenue above previous guidance, sparking fresh investor attention. See our latest analysis for Surf Air Mobility. This fresh capital injection and upbeat Q3 revenue outlook follow a string of recent milestones for Surf Air Mobility, including the completion of a follow-on equity offering and upcoming...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...